SCHEMBL7585358

SCHEMBL7585358

O=C(O)C(Nc1cc(Br)ccc1Br)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 1/20 0.49
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.43
ALDH1A1 P00352 6/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
LMNA P02545 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2C9 P11712 1/20 0.40
PKM P14618 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
THRB P10828 1/20 0.40
BLM P54132 1/20 0.40
BTK Q06187 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PLK3 Q9H4B4 1/20 0.40
S1PR3 Q99500 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7577631 0.88 FPR2 (0.49) FPR2POLBL3MBTL1ALDH1A1KMT2A
SCHEMBL7582089 0.83 FPR2 (0.46) FPR2L3MBTL1ALDH1A1KMT2AMEN1
SCHEMBL7574119 0.82 ALDH1A1 (0.56) FPR2L3MBTL1ALDH1A1KMT2AMEN1
SCHEMBL18360852 0.77 ALDH1A1 (0.57) FPR2POLBL3MBTL1ALDH1A1LMNA
SCHEMBL7583413 0.77 FPR2 (0.67) FPR2ALDH1A1KMT2AMEN1LMNA
SCHEMBL7576266 0.76 CA1 (0.51) FPR2POLBALDH1A1KMT2AMEN1
SCHEMBL7574039 0.75 FPR2 (0.47) FPR2ALDH1A1LMNACA1CA2
SCHEMBL11203574 0.74 KMT2A (0.51) FPR2ALDH1A1KMT2AMEN1CA2
SCHEMBL839473 0.74 MEN1 (0.50) FPR2L3MBTL1ALDH1A1KMT2AMEN1
SCHEMBL9298169 0.73 FPR2 (0.47) FPR2ALDH1A1KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed